34 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
obtaining adequate new debt or equity financings.
The report of our independent registered accounting firm on our audited financial statements … and Market Advantage
Ketamir-2’s market opportunity and market advantage was analyzed by IQVIA who were contracted to perform an independent Market
8-K
EX-10.1
MIRA
Mira Pharmaceuticals Inc
20 Nov 23
MIRA Pharmaceuticals Announces Exclusive Licensing Agreement for Oral Ketamine Analog, Ketamir-2
8:10am
consultants, agents or independent contractors of the receiving party who are hired or engaged by the receiving party shall hold in confidence any
8-K
EX-1.1
MIRA
Mira Pharmaceuticals Inc
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
; or (ii) declared or paid any dividend or made any other distribution on or in respect to its capital stock.
2.6. Independent Accountants. Cherry Bekaert … and the Prospectus, is an independent registered public accounting firm as required by the Securities Act and the Securities Act Regulations and the Public Company
8-K
EX-4.1
MIRA
Mira Pharmaceuticals Inc
7 Aug 23
MIRA Pharmaceuticals, Inc. Announces Pricing of $8.9 Million Initial
5:14pm
includes an underwritten public offering, a letter dated the date of the closing under the underwriting agreement) signed by the independent registered … with its officers and independent auditors, all to such reasonable extent and at such reasonable times as any such Holder shall reasonably request.
4.3.4
424B4
uzqvva dwbdu
4 Aug 23
Prospectus supplement with pricing info
1:01pm
424B1
pqqpkl
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-99.1
sdgneqxhfou32aw8n
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.4
mvkzfh9ic vpkuzlv
29 Jun 23
IPO registration
4:39pm
S-1
EX-23.1
l1pkic4
29 Jun 23
IPO registration
4:39pm